Founded in 2006 in Richardson, Texas, our flagship location has Phase I-IV capabilities with a dedicated outpatient program and a 60-bed inpatient research unit.
Based near the heart of downtown Chicago and opened in 2018, this site conducts Phase I-IV studies and features outpatient space, a 24-bed inpatient research unit, and a dedicated Phase I unit with 50 beds.
Located in Arkansas' capital and established in 2022, this facility conducts Phase I-IV studies and features an 8-bed inpatient unit and outpatient space.
This modern center in Northwest Arkansas opened in 2019 and conducts Phase I-IV inpatient and outpatient studies. This location features a 24-bed inpatient unit, a 24-bed Phase I unit, and an indoor smoking lounge.
DALLAS
CHICAGO
NORTHWEST ARKANSAS
CENTRAL ARKANSAS
Business Hours
Monday – Friday
8:30 a.m. – 5 p.m.
Sign up to receive updates, promotions, and sneak peaks of Swab Test.
